These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22300406)

  • 1. Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model.
    Maloney B; Sambamurti K; Zawia N; Lahiri DK
    Curr Alzheimer Res; 2012 Jun; 9(5):589-99. PubMed ID: 22300406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD.
    Lahiri DK; Maloney B; Basha MR; Ge YW; Zawia NH
    Curr Alzheimer Res; 2007 Apr; 4(2):219-28. PubMed ID: 17430250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AD "Statin": Alzheimer's Disorder is a "Fast" Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2020; 2(1):75-89. PubMed ID: 32201863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
    Gandy S; Petanceska S
    Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps.
    Lahiri DK; Maloney B
    Exp Gerontol; 2010 Apr; 45(4):291-6. PubMed ID: 20064601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease: a dysfunction of the amyloid precursor protein(1).
    Neve RL; McPhie DL; Chen Y
    Brain Res; 2000 Dec; 886(1-2):54-66. PubMed ID: 11119687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What causes alzheimer's disease?
    Armstrong RA
    Folia Neuropathol; 2013; 51(3):169-88. PubMed ID: 24114635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics, oxidative stress, and Alzheimer disease.
    Zawia NH; Lahiri DK; Cardozo-Pelaez F
    Free Radic Biol Med; 2009 May; 46(9):1241-9. PubMed ID: 19245828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" model.
    Lahiri DK; Zawia NH; Greig NH; Sambamurti K; Maloney B
    Biogerontology; 2008 Dec; 9(6):375-9. PubMed ID: 18668339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental risk factors and the developmental basis for Alzheimer's disease.
    Zawia NH; Basha MR
    Rev Neurosci; 2005; 16(4):325-37. PubMed ID: 16519009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid, neuronal death and Alzheimer's disease.
    Carter J; Lippa CF
    Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do epigenetic pathways initiate late onset Alzheimer disease (LOAD): towards a new paradigm.
    Bihaqi SW; Schumacher A; Maloney B; Lahiri DK; Zawia NH
    Curr Alzheimer Res; 2012 Jun; 9(5):574-88. PubMed ID: 22300405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.
    Sambamurti K; Greig NH; Lahiri DK
    Neuromolecular Med; 2002; 1(1):1-31. PubMed ID: 12025813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.
    Wu J; Basha MR; Brock B; Cox DP; Cardozo-Pelaez F; McPherson CA; Harry J; Rice DC; Maloney B; Chen D; Lahiri DK; Zawia NH
    J Neurosci; 2008 Jan; 28(1):3-9. PubMed ID: 18171917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of Alzheimer's disease and aging.
    Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
    Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.